mTORC2 mediate FLCN-induced HIF2α nuclear import and proliferation of clear cell renal cell carcinoma
X. Zhao, Y. Ma, J. Cui, H. Zhao, L. Liu, Y. Wang, P. Min, L. Zhang, Y. Chen, J. Du, Y. Zhang, L. Gu
Abstract
Clear cell renal cell carcinoma (ccRCC), as the most important type of renal carcinoma, has a high incidence and easy metastasis. Folliculin (FLCN) was identified as a tumor suppressor gene. Its deletions and mutations are associated with a potential risk of kidney cancer. At present, the specific molecular mechanism of FLCN-induced proliferation, invasion and migration in clear cell renal cell carcinoma remains elusive. In this study, we demonstrated that FLCN controled cell proliferation, invasion and migration through PI3K/mTORC2 pathway. FLCN combined with HIF2 in various normal and cancerous renal cells, and mTORC2 mediate FLCN effectively alleviated the deterioration of renal cancer cells by degrading HIF2. Silencing of FLCN showed promotion of HIF2 protein expression, which in turn led to an increase in downstream target genes Cyclin D1 and MMP9. Moreover, when interfering with siFLCN, HIF2 degradation rate was delayed, and the time of entry into the nucleus was advanced. Taken together, our study illustrated that mTORC2 promoted the specific molecular mechanism of HIF2 by down-regulated FLCN, and might be a new therapeutic target against renal cancer progression.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- ACSS2 Regulates HIF-2α Degradation through the E3-Ubiquitin Ligase MUL1 in Clear Cell Renal Cell Carcinoma
Z. A. Bacigalupa, W. A. Brown, … W. K. Rathmell·bioRxiv·Apr 21, 2022
- Combined Loss of VHL and TSC1 Drives Clear Cell Renal Cell Carcinoma with Metabolic and Redox Reprogramming that Creates an NRF2 Dependency
Jianing Xu, Xiaoqing Cheng, … James J.-D. Hsieh·bioRxiv·Sep 28, 2026
- ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma
Y. Song Green, M. C. Ferreira dos Santos, … M. Y. Koh·bioRxiv·Jun 1, 2022
- BMAL1-HIF2α heterodimers contribute to ccRCC
Rebecca Mello, Diego Gomez Ceballos, … Katja A Lamia·Nature CommunicationsPeer-reviewed·Jul 1, 2025
- HIF2-driven PTHrP Causes Cachexia and Hypercalcemia in Kidney Cancer: Treatment with HIF2 Inhibitors
Muhannad Abu‐Remaileh, Laura A. Stransky, … William G. Kaelin·Nature MedicinePeer-reviewed·Nov 28, 2025
- SET1B drives sustained HIF activity and disease progression in clear cell renal cell carcinoma.
Brian M. Ortmann, Tekle Pauzaite, … James A. Nathan·Cancer ResearchPeer-reviewed·Apr 6, 2026